Menu
Back to Journals » Drug, Healthcare and Patient Safety » Volume 3
Perspectives
Should benefit–risk assessment have its own drug “label”?
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,647 | Dovepress* | 8,841+ | 1,838 | 10,679 | |
| PubMed Central* | 806 | 159 | 965 | ||
| Totals | 9,647 | 1,997 | 11,644 | ||
|
*Since 3 August 2011 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 7 | 0 | 0 | 0 | 3 | 4 |
View citations on PubMed Central and Google Scholar